The signaling events that are induced by inflammatory mediators, in an osteoarthritis context, lead to the NF-κB activation and to pro-inflammatory gene expression as previously mentioned, but this is also the case in IBD [67]. The gene discussed is NFKB1; the disease is irritable bowel syndrome.